Potencial terapêutico de flavonoides na síndrome dos ovários policísticos e complicações clínicas associadas

Detalhes bibliográficos
Autor(a) principal: Oliveira, Anne Karoline de Souza
Data de Publicação: 2022
Tipo de documento: Tese
Idioma: por
Título da fonte: Repositório Institucional da UFS
Texto Completo: https://ri.ufs.br/jspui/handle/riufs/18471
Resumo: Polycystic Ovary Syndrome (PCOS) is an endocrinopathy that commonly affects women of reproductive age and is associated with hyperandrogenism, ovarian dysfunction, insulin resistance, cardiometabolic complications and infertility. Hesperitin (HST) is a flavonoid with biological potential and stands out for its ability to modulate genes involved in the inflammatory process and redox homeostasis. Therefore, the objective of the present work was to gather scientific evidence on the biological properties and molecular targets of flavonoids in endocrine and metabolic disorders associated with PCOS, through systematic reviews, and to evaluate the effect of the HST-OH-γ-CD complex ( hesperitin-hydroxypropyl-γ-cyclodextrin) in the modulation of PCOS in an animal model. The first systematic review showed that the antiobesogenic properties of flavonoids are associated with modulation of proteins, transcription factors and target genes involved in adipogenesis, lipolysis, glucose metabolism, inflammation and oxidative stress. The findings described in the second review highlight that the mechanisms underlying the therapeutic potential of flavonoids are associated with their anti-inflammatory, antioxidant, lipid-lowering, anti-apoptotic, and regulatory target genes involved in steroidogenesis and intracellular insulin signaling. The effect of the HST-OH-γ-CD complex on PCOS modulation was evaluated in a letrozole-induced model. Initially, the antioxidant activity of HST was evaluated by different models in vitro and, in cell culture of macrophages against the production of ROS (reactive oxygen species), induced by hydrogen peroxide. The antioxidant action of the flavonoid HST was mainly associated with its potential to donate hydrogens, neutralizing radical species. For induction of PCOS, adult Wistar rats received letrozole (1mg/kg of body weight, orally) for 21 days. After induction of PCOS, confirmed by the presence of irregular estrous cycles, the animals were treated with free and complexed HST (200 mg/kg of body weight, orally) for another 21 days. At the end of the treatment, the rats were euthanized. Blood was collected for quantification of biochemical parameters. Ovaries, uterus, liver, periovarian adipose tissue and retroperitoneal measurement were collected for weight measurement. Ovarian tissues were collected for histological analysis and for the analysis of oxidative stress markers and quantification of proteins involved in folliculogenesis. For tabulation and statistical analysis of the data, the Prism 7 software (GraphPad) with analysis of variance (ANOVA) was used, followed by the Tukey test. The results of the preclinical trial showed that complexed HST aided in tissue weight loss of fat pads and restored the architecture of ovarian follicular cells. This effect was associated with a reduction in serum levels of total testosterone and body fat deposition, in addition to the maintenance of p-Akt/Akt indices in ovarian tissue. It is worth noting here the relevance of the complexation of hydrophobic molecules in cyclodextrins, which in the present study, potentiated the pharmacological effects of the flavonoid HST. As far as we know, our study is the first to demonstrate the promising potential of complexed HST against endocrine, reproductive and metabolic disorders characteristic of PCOS, providing support for pre-clinical and clinical trials that use complexed HST as an alternative therapeutic strategy in the management of PCOS.
id UFS-2_617afc3e9ab39ed9222321c6cd3e90e6
oai_identifier_str oai:ufs.br:riufs/18471
network_acronym_str UFS-2
network_name_str Repositório Institucional da UFS
repository_id_str
spelling Oliveira, Anne Karoline de SouzaQuintans, Jullyana de Souza SiqueiraSilva, Ana Mara de Oliveira e2023-10-06T14:32:05Z2023-10-06T14:32:05Z2022OLIVEIRA, Anne Karoline de Souza. Potencial terapêutico de flavonoides na síndrome dos ovários policísticos e complicações clínicas associadas. 2022. 155f. Tese (doutorado em Ciências da Saúde) – Universidade Federal de Sergipe, Aracaju, 2022.https://ri.ufs.br/jspui/handle/riufs/18471Polycystic Ovary Syndrome (PCOS) is an endocrinopathy that commonly affects women of reproductive age and is associated with hyperandrogenism, ovarian dysfunction, insulin resistance, cardiometabolic complications and infertility. Hesperitin (HST) is a flavonoid with biological potential and stands out for its ability to modulate genes involved in the inflammatory process and redox homeostasis. Therefore, the objective of the present work was to gather scientific evidence on the biological properties and molecular targets of flavonoids in endocrine and metabolic disorders associated with PCOS, through systematic reviews, and to evaluate the effect of the HST-OH-γ-CD complex ( hesperitin-hydroxypropyl-γ-cyclodextrin) in the modulation of PCOS in an animal model. The first systematic review showed that the antiobesogenic properties of flavonoids are associated with modulation of proteins, transcription factors and target genes involved in adipogenesis, lipolysis, glucose metabolism, inflammation and oxidative stress. The findings described in the second review highlight that the mechanisms underlying the therapeutic potential of flavonoids are associated with their anti-inflammatory, antioxidant, lipid-lowering, anti-apoptotic, and regulatory target genes involved in steroidogenesis and intracellular insulin signaling. The effect of the HST-OH-γ-CD complex on PCOS modulation was evaluated in a letrozole-induced model. Initially, the antioxidant activity of HST was evaluated by different models in vitro and, in cell culture of macrophages against the production of ROS (reactive oxygen species), induced by hydrogen peroxide. The antioxidant action of the flavonoid HST was mainly associated with its potential to donate hydrogens, neutralizing radical species. For induction of PCOS, adult Wistar rats received letrozole (1mg/kg of body weight, orally) for 21 days. After induction of PCOS, confirmed by the presence of irregular estrous cycles, the animals were treated with free and complexed HST (200 mg/kg of body weight, orally) for another 21 days. At the end of the treatment, the rats were euthanized. Blood was collected for quantification of biochemical parameters. Ovaries, uterus, liver, periovarian adipose tissue and retroperitoneal measurement were collected for weight measurement. Ovarian tissues were collected for histological analysis and for the analysis of oxidative stress markers and quantification of proteins involved in folliculogenesis. For tabulation and statistical analysis of the data, the Prism 7 software (GraphPad) with analysis of variance (ANOVA) was used, followed by the Tukey test. The results of the preclinical trial showed that complexed HST aided in tissue weight loss of fat pads and restored the architecture of ovarian follicular cells. This effect was associated with a reduction in serum levels of total testosterone and body fat deposition, in addition to the maintenance of p-Akt/Akt indices in ovarian tissue. It is worth noting here the relevance of the complexation of hydrophobic molecules in cyclodextrins, which in the present study, potentiated the pharmacological effects of the flavonoid HST. As far as we know, our study is the first to demonstrate the promising potential of complexed HST against endocrine, reproductive and metabolic disorders characteristic of PCOS, providing support for pre-clinical and clinical trials that use complexed HST as an alternative therapeutic strategy in the management of PCOS.A Síndrome dos Ovários Policísticos (SOP) é uma endocrinopatia que acomete comumente mulheres em idade reprodutiva e, está associada ao hiperandrogenismo, disfunção ovariana, resistência insulínica, complicações cardiometabólicas e infertilidade. A hesperitina (HST) é um flavonoide com potenciais biológicos e, se destaca por sua capacidade de modular genes envolvidos no processo inflamatório e na homeostase redox. Logo, o objetivo do presente trabalho foi reunir evidências científicas, sobre as propriedades biológicas e alvos moleculares dos flavonoides em distúrbios endócrinos e metabólicos associados à SOP, por meio de revisões sistemática e, avaliar o efeito do complexo HST-OH-γ-CD (hesperitina- hidroxipropil-γ-ciclodextrina) na modulação da SOP em modelo animal. A primeira revisão sistemática mostrou que as propriedades antiobesogênicas dos flavonoides estão associadas a modulação de proteínas, fatores de transcrição e genes-alvo envolvidos na adipogênese, lipólise, metabolismo glicídico, inflamação e estresse oxidativo. Os achados descritos na segunda revisão, destacam que os mecanismos subjacentes ao potencial terapêutico dos flavonoides estão associados às suas atividades anti-inflamatórias, antioxidantes, hipolipemiantes, antiapoptótocas, e reguladoras de genes-alvo envolvidos na esteroidogênese e na sinalização intracelular da insulina. O efeito do complexo HST-OH- γ-CD sobre a modulação da SOP, foi avaliado em modelo induzido por letrozol. Inicialmente a atividade antioxidante da HST foi avaliada por distintos modelos in vitro e, em cultura celular de macrófagos frente a produção de ERO (espécies reativas de oxigênio), induzida por peróxido de hidrogênio. A ação antioxidante do flavonoide HST foi associada principalmente ao seu potencial de doar hidrogênios, neutralizando espécies radicalares. Para indução da SOP, ratas Wistar adultas receberam letrozol (1mg/kg de peso, via oral) durante 21 dias. Após indução da SOP, confirmada pela presença de ciclos estrais irregulares, os animais foram tratados HST livre e complexada (200 mg/kg de peso, via oral) por mais 21 dias. Ao final do tratamento, as ratas foram eutanasiadas. O sangue foi coletadado para quantificação de parâmetros bioquímicos. Foram coletados ovários, útero, fígado, tecido adiposo periovariano e retroperitoneal aferição para aferição de peso. O tecidos ovariano foi coletado para análise histológica e para análise de marcadores de estresse oxidativo e quantificação de proteínas envolvidas na foliculogênese. Para tabulação e análise estatística dos dados foi utilizado o software Prism 7 (GraphPad) com análise de variância (ANOVA), seguida do teste Tukey. Os resultados do ensaio pré-clínico mostraram que a HST complexada auxiliou na perda de peso tecidual de coxins adiposos e restaurou a arquitetura de células foliculares ovarianas. Esse efeito foi associado a redução dos níveis séricos de testosterona total e da deposição de gordura corporal, além da manutenção dos ínidices de p-Akt/Akt no tecido ovariano. Cabe aqui ressaltar a relevância da complexação de moléculas hidrofóbicas em ciclodextrinas, que no presente estudo, potencializou os efeitos farmacológicos do flavonoide HST. Até onde sabemos, nosso estudo é o primeiro a demonstrar o potencial promissor da HST complexada frente à distúrbios endócrinos, reprodutivos e metabólicos característicos à SOP, fornecendo subsídios para ensaios pré-clínicos e clínicos que utilizem a HST complexada como estratégia terapêutica alternativa no manejo da SOP.AracajuporSíndrome dos ovários policísticos (SOP)FlavonoidesHiperandrogenismoDisfunção ovulatóriaTecido adiposoPolycystic ovary syndrome (PCOS)FlaavonoidsHiperandrogenismOvulatory disfunctionsAdipose tissueCIENCIAS DA SAUDE::MEDICINAPotencial terapêutico de flavonoides na síndrome dos ovários policísticos e complicações clínicas associadasPotencial terapêutico de flavonoides na síndrome dos ovários policísticos e distúrbios associadosinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisPós-Graduação em Ciências da SaúdeUniversidade Federal de Sergipereponame:Repositório Institucional da UFSinstname:Universidade Federal de Sergipe (UFS)instacron:UFSinfo:eu-repo/semantics/openAccessLICENSElicense.txtlicense.txttext/plain; charset=utf-81475https://ri.ufs.br/jspui/bitstream/riufs/18471/1/license.txt098cbbf65c2c15e1fb2e49c5d306a44cMD51ORIGINALAnne_Karoline_Oliveira.pdfAnne_Karoline_Oliveira.pdfapplication/pdf3134990https://ri.ufs.br/jspui/bitstream/riufs/18471/2/Anne_Karoline_Oliveira.pdfd11caadb63e3b28e4287b2931451b076MD52riufs/184712023-10-06 11:32:10.753oai:ufs.br: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Repositório InstitucionalPUBhttps://ri.ufs.br/oai/requestrepositorio@academico.ufs.bropendoar:2023-10-06T14:32:10Repositório Institucional da UFS - Universidade Federal de Sergipe (UFS)false
dc.title.pt_BR.fl_str_mv Potencial terapêutico de flavonoides na síndrome dos ovários policísticos e complicações clínicas associadas
dc.title.alternative.por.fl_str_mv Potencial terapêutico de flavonoides na síndrome dos ovários policísticos e distúrbios associados
title Potencial terapêutico de flavonoides na síndrome dos ovários policísticos e complicações clínicas associadas
spellingShingle Potencial terapêutico de flavonoides na síndrome dos ovários policísticos e complicações clínicas associadas
Oliveira, Anne Karoline de Souza
Síndrome dos ovários policísticos (SOP)
Flavonoides
Hiperandrogenismo
Disfunção ovulatória
Tecido adiposo
Polycystic ovary syndrome (PCOS)
Flaavonoids
Hiperandrogenism
Ovulatory disfunctions
Adipose tissue
CIENCIAS DA SAUDE::MEDICINA
title_short Potencial terapêutico de flavonoides na síndrome dos ovários policísticos e complicações clínicas associadas
title_full Potencial terapêutico de flavonoides na síndrome dos ovários policísticos e complicações clínicas associadas
title_fullStr Potencial terapêutico de flavonoides na síndrome dos ovários policísticos e complicações clínicas associadas
title_full_unstemmed Potencial terapêutico de flavonoides na síndrome dos ovários policísticos e complicações clínicas associadas
title_sort Potencial terapêutico de flavonoides na síndrome dos ovários policísticos e complicações clínicas associadas
author Oliveira, Anne Karoline de Souza
author_facet Oliveira, Anne Karoline de Souza
author_role author
dc.contributor.author.fl_str_mv Oliveira, Anne Karoline de Souza
dc.contributor.advisor1.fl_str_mv Quintans, Jullyana de Souza Siqueira
dc.contributor.advisor-co1.fl_str_mv Silva, Ana Mara de Oliveira e
contributor_str_mv Quintans, Jullyana de Souza Siqueira
Silva, Ana Mara de Oliveira e
dc.subject.por.fl_str_mv Síndrome dos ovários policísticos (SOP)
Flavonoides
Hiperandrogenismo
Disfunção ovulatória
Tecido adiposo
topic Síndrome dos ovários policísticos (SOP)
Flavonoides
Hiperandrogenismo
Disfunção ovulatória
Tecido adiposo
Polycystic ovary syndrome (PCOS)
Flaavonoids
Hiperandrogenism
Ovulatory disfunctions
Adipose tissue
CIENCIAS DA SAUDE::MEDICINA
dc.subject.eng.fl_str_mv Polycystic ovary syndrome (PCOS)
Flaavonoids
Hiperandrogenism
Ovulatory disfunctions
Adipose tissue
dc.subject.cnpq.fl_str_mv CIENCIAS DA SAUDE::MEDICINA
description Polycystic Ovary Syndrome (PCOS) is an endocrinopathy that commonly affects women of reproductive age and is associated with hyperandrogenism, ovarian dysfunction, insulin resistance, cardiometabolic complications and infertility. Hesperitin (HST) is a flavonoid with biological potential and stands out for its ability to modulate genes involved in the inflammatory process and redox homeostasis. Therefore, the objective of the present work was to gather scientific evidence on the biological properties and molecular targets of flavonoids in endocrine and metabolic disorders associated with PCOS, through systematic reviews, and to evaluate the effect of the HST-OH-γ-CD complex ( hesperitin-hydroxypropyl-γ-cyclodextrin) in the modulation of PCOS in an animal model. The first systematic review showed that the antiobesogenic properties of flavonoids are associated with modulation of proteins, transcription factors and target genes involved in adipogenesis, lipolysis, glucose metabolism, inflammation and oxidative stress. The findings described in the second review highlight that the mechanisms underlying the therapeutic potential of flavonoids are associated with their anti-inflammatory, antioxidant, lipid-lowering, anti-apoptotic, and regulatory target genes involved in steroidogenesis and intracellular insulin signaling. The effect of the HST-OH-γ-CD complex on PCOS modulation was evaluated in a letrozole-induced model. Initially, the antioxidant activity of HST was evaluated by different models in vitro and, in cell culture of macrophages against the production of ROS (reactive oxygen species), induced by hydrogen peroxide. The antioxidant action of the flavonoid HST was mainly associated with its potential to donate hydrogens, neutralizing radical species. For induction of PCOS, adult Wistar rats received letrozole (1mg/kg of body weight, orally) for 21 days. After induction of PCOS, confirmed by the presence of irregular estrous cycles, the animals were treated with free and complexed HST (200 mg/kg of body weight, orally) for another 21 days. At the end of the treatment, the rats were euthanized. Blood was collected for quantification of biochemical parameters. Ovaries, uterus, liver, periovarian adipose tissue and retroperitoneal measurement were collected for weight measurement. Ovarian tissues were collected for histological analysis and for the analysis of oxidative stress markers and quantification of proteins involved in folliculogenesis. For tabulation and statistical analysis of the data, the Prism 7 software (GraphPad) with analysis of variance (ANOVA) was used, followed by the Tukey test. The results of the preclinical trial showed that complexed HST aided in tissue weight loss of fat pads and restored the architecture of ovarian follicular cells. This effect was associated with a reduction in serum levels of total testosterone and body fat deposition, in addition to the maintenance of p-Akt/Akt indices in ovarian tissue. It is worth noting here the relevance of the complexation of hydrophobic molecules in cyclodextrins, which in the present study, potentiated the pharmacological effects of the flavonoid HST. As far as we know, our study is the first to demonstrate the promising potential of complexed HST against endocrine, reproductive and metabolic disorders characteristic of PCOS, providing support for pre-clinical and clinical trials that use complexed HST as an alternative therapeutic strategy in the management of PCOS.
publishDate 2022
dc.date.issued.fl_str_mv 2022
dc.date.accessioned.fl_str_mv 2023-10-06T14:32:05Z
dc.date.available.fl_str_mv 2023-10-06T14:32:05Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv OLIVEIRA, Anne Karoline de Souza. Potencial terapêutico de flavonoides na síndrome dos ovários policísticos e complicações clínicas associadas. 2022. 155f. Tese (doutorado em Ciências da Saúde) – Universidade Federal de Sergipe, Aracaju, 2022.
dc.identifier.uri.fl_str_mv https://ri.ufs.br/jspui/handle/riufs/18471
identifier_str_mv OLIVEIRA, Anne Karoline de Souza. Potencial terapêutico de flavonoides na síndrome dos ovários policísticos e complicações clínicas associadas. 2022. 155f. Tese (doutorado em Ciências da Saúde) – Universidade Federal de Sergipe, Aracaju, 2022.
url https://ri.ufs.br/jspui/handle/riufs/18471
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.program.fl_str_mv Pós-Graduação em Ciências da Saúde
dc.publisher.initials.fl_str_mv Universidade Federal de Sergipe
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFS
instname:Universidade Federal de Sergipe (UFS)
instacron:UFS
instname_str Universidade Federal de Sergipe (UFS)
instacron_str UFS
institution UFS
reponame_str Repositório Institucional da UFS
collection Repositório Institucional da UFS
bitstream.url.fl_str_mv https://ri.ufs.br/jspui/bitstream/riufs/18471/1/license.txt
https://ri.ufs.br/jspui/bitstream/riufs/18471/2/Anne_Karoline_Oliveira.pdf
bitstream.checksum.fl_str_mv 098cbbf65c2c15e1fb2e49c5d306a44c
d11caadb63e3b28e4287b2931451b076
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFS - Universidade Federal de Sergipe (UFS)
repository.mail.fl_str_mv repositorio@academico.ufs.br
_version_ 1802110829156368384